New study aims to unlock secrets of rare brain disease in children

NCT ID NCT05659901

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study is following 32 boys aged 6 months to 17 years with Pelizaeus-Merzbacher disease (PMD), a rare genetic disorder affecting the brain's white matter. Researchers are measuring biomarkers in spinal fluid and blood, brain scans, and motor and cognitive skills over time. The goal is to better understand how PMD progresses, which could help develop future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could identify key markers of PMD progression, helping researchers design better treatments for this rare disease.
What could go wrong
This is an observational study, not a treatment trial. It may not directly benefit participants, and results may not lead to immediate therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PELIZAEUS-MERZBACHER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ionis Investigative Site

    RECRUITING

    Atlanta, Georgia, 30342, United States

  • Ionis Investigative Site

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Ionis Investigative Site

    ACTIVE_NOT_RECRUITING

    Clermont-Ferrand, France

  • Ionis Investigative Site

    ACTIVE_NOT_RECRUITING

    Le Kremlin-Bicêtre, 94270, France

  • Ionis Investigative Site

    ACTIVE_NOT_RECRUITING

    Göttingen, Germany

  • Ionis Investigative Site

    RECRUITING

    Tel Aviv, 6423906, Israel

  • Ionis Investigative Site

    RECRUITING

    Milan, 20154, Italy

  • Ionis Investigative Site

    RECRUITING

    Amsterdam, 1081 HV, Netherlands

  • Ionis Investigative Site

    RECRUITING

    Leeds, LS1 3EX, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.